Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17136040 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Evaluation of the Efficacy and Tolerance of B-Back® on the Burnout Syndrome
Condition: Efficacy and Tolerance of B-Back® on the Burnout Syndrome
Interventions: Dietary Supplement: Dietary supplement : B-Back® (α-casozepine, taurine, eleutherococcus senticosus, Extramel);   Dietary Supplement: B-Back® placebo (without active compounds)

Indicates status has not been verified in more than two years